ArticleCanadian journal of public health = Revue canadienne de sante publique2025
Naloxone awareness and acquisition: Findings from the 2021‒2022 Canadian Postsecondary Education Alcohol and Drug Use Survey.
Article in Canadian journal of public health = Revue canadienne de sante publique, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Responding to the toxic drug crisis: Promising innovations, gaps, and calls to action.Canadian journal of public health = Revue canadienne de sante publique · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThis cross-sectional study assessed naloxone awareness, acquisition rates, and reasons for acquisition among postsecondary students in Canada aged 17‒25 years.
methodsUsing data from the 2021‒2022 Canadian Postsecondary Education Alcohol and Drug Use Survey, we conducted descriptive analyses of 31,643 students to characterize naloxone awareness, acquisition, and reasons for acquisition overall and by age, gender, race, international student status, and opioid pain reliever (OPR) use. Using multivariable logistic regression, we assessed the relationship between demographic variables and naloxone awareness and acquisition.
resultsAmong postsecondary students in Canada, only 47% had heard of naloxone, and only 5% had acquired it in the past year. Significant predictors of naloxone awareness and acquisition included gender, age, race, international student status, and OPR use. Older students, non-binary students, domestic students, and Indigenous students had higher odds of both naloxone awareness and acquisition. Students who had used OPRs in the past year were less likely to be aware of naloxone (AOR = 0.85, 95% CI: 0.80-0.91). However, among those who were aware, they were more likely to have acquired naloxone (AOR = 1.16, 95% CI: 1.01-1.34) than those who had not used OPRs. Among students who had acquired naloxone in the past year, 97% reported their main reason for obtaining it was for use in emergencies involving other people.
conclusionLow naloxone awareness and acquisition among postsecondary students in Canada represent an important public health gap. Increasing naloxone awareness and acquisition may play an important role in enhancing safety on campuses and beyond.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.